Q3 2024 HLS Therapeutics Inc Earnings Call Transcript
Good morning and welcome to the Q3 fiscal '2024 financial results conference call for a HLS Therapeutics. At this point, I would like to turn the call over to Dave Mason, Investor Relations for the introductory mark.
Good morning, everyone. And thank you for joining us today. With me in the room on the call. We have Craig Millian, Chief Executive Officer; John Hanna, Chief Financial Officer; and Brian T. Walsh, Chief Commercial Officer.
Earlier this morning, we issued a news release announcing our financial results for the three and nine months ended, September 30, 2024. This news release along with our s MD&A and financial statements is available on our website and our SEDAR+.
Please note that slides accompanying today's call can be viewed via the live webcast. A link to which is available in our earnings press release and at our website on the events page, certain matters discussed in today's conference call or answers that may be given to questions could constitute forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |